AU3064800A - The therapeutic use of r-warfarin as anticoagulant - Google Patents
The therapeutic use of r-warfarin as anticoagulantInfo
- Publication number
- AU3064800A AU3064800A AU30648/00A AU3064800A AU3064800A AU 3064800 A AU3064800 A AU 3064800A AU 30648/00 A AU30648/00 A AU 30648/00A AU 3064800 A AU3064800 A AU 3064800A AU 3064800 A AU3064800 A AU 3064800A
- Authority
- AU
- Australia
- Prior art keywords
- warfarin
- anticoagulant
- therapeutic use
- therapeutic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A61K31/37—Coumarins, e.g. psoralen
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9901297.3A GB9901297D0 (en) | 1999-01-21 | 1999-01-21 | Diagnostic test and method |
GB9901297 | 1999-01-21 | ||
GBGB9912184.0A GB9912184D0 (en) | 1999-05-25 | 1999-05-25 | Therapeutic use |
GB9912184 | 1999-05-25 | ||
PCT/GB2000/000154 WO2000043003A1 (en) | 1999-01-21 | 2000-01-21 | The therapeutic use of r-warfarin as anticoagulant |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3064800A true AU3064800A (en) | 2000-08-07 |
Family
ID=26315012
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU30648/00A Abandoned AU3064800A (en) | 1999-01-21 | 2000-01-21 | The therapeutic use of r-warfarin as anticoagulant |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3064800A (en) |
WO (1) | WO2000043003A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040084867A1 (en) * | 2002-06-28 | 2004-05-06 | Xanthus Life Sciences, Inc. | Individualization of therapy with anticoagulants |
EP1673450B1 (en) | 2003-10-14 | 2010-04-28 | Baxter International Inc. | Vitamin k epoxide recycling polypeptide vkorc1, a therapeutic target of coumarin and their derivatives |
US20090325226A1 (en) | 2005-03-15 | 2009-12-31 | Stafford Darrel W | Methods and Compositions for Producing Active Vitamin K-Dependent Proteins |
WO2008082542A1 (en) * | 2006-12-19 | 2008-07-10 | Institute For Therapeutic Research, Inc. | Combination of vitamin k and vitamin k antagonist such as r-isomer of warfarin, phenprocoumon or r-isomer of phenprocoumon as anticoagulant therapy |
US9631002B2 (en) | 2010-12-21 | 2017-04-25 | The University Of North Carolina At Chapel Hill | Methods and compositions for producing active vitamin K-dependent proteins |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2860295A (en) * | 1994-06-16 | 1996-01-05 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Defects in drug metabolism |
PT839142E (en) * | 1995-07-13 | 2001-12-28 | Du Pont Pharm Co | NEW ASYMMETRIC SYNTHESIS OF THE VARFARINA AND OF THOSE ANALOGS |
WO1998040053A1 (en) * | 1997-03-11 | 1998-09-17 | Darwin Discovery Limited | Dosage forms comprising separate portions of r- and s-enantiomers |
-
2000
- 2000-01-21 WO PCT/GB2000/000154 patent/WO2000043003A1/en active Application Filing
- 2000-01-21 AU AU30648/00A patent/AU3064800A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2000043003A1 (en) | 2000-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1212327B8 (en) | Pyrazolopyrimidines as therapeutic agents | |
AU2955200A (en) | Cannula | |
AU5259100A (en) | Medicament | |
AU4248000A (en) | Methods of use of the taci/taci-l interaction | |
AU2730600A (en) | Medical adhesives | |
AU2919001A (en) | Syringe | |
AU4431000A (en) | Novel use | |
AU7377200A (en) | Combination therapy including camptothecin | |
AU2001260834A1 (en) | The treatment of herpes | |
AU2292301A (en) | Human kinases | |
AU2451500A (en) | Therapeutic agents | |
AU5547000A (en) | Novel treatment | |
AU3978700A (en) | Medical use | |
AU2021601A (en) | Composition for the treatment of dandruff | |
AU1878201A (en) | Composition for the treatment of damaged tissue | |
AU3064800A (en) | The therapeutic use of r-warfarin as anticoagulant | |
AU6051600A (en) | Medical tubing | |
AU5973600A (en) | Therapeutic agents | |
AU3714800A (en) | Hiv therapy | |
AU1043601A (en) | Medical use | |
AU4456800A (en) | Human hac3 | |
AU1405001A (en) | Treatment of diseases | |
AU5866600A (en) | The use of human fgh-8 polypeptides as neurotrophic agents | |
AU2683500A (en) | Compositions for the treatment of pain | |
AU3133400A (en) | Syringe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |